14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Multidrug resistant (MDR) tuberculosis (TB) represents TB which is simultaneous resistant to at least rifampicin (R) and isoniazid (H). Identifying inadequate therapy as the main cause of this form of the disease and explaining the factors leading to its occurrence, numerous social determinants that affect the risk of developing resistance are highlighted. The objectives of the study was to identify independent factors of MDR-TB among tuberculosis patients.

          Methods

          Case-control study was conducted from 1st September 2009 to 1st June 2014 in 31 healthcare institutions in Serbia where MDR-TB and TB patients were treated. TB patients infected with MDR- M. tuberculosis and non MDR- M. tuberculosis strain were considered as cases and controls, respectively. Cases and controls were matched by the date of hospitalization. The data was collected using structured questionnaire with face to face interview. Bivariate and multivariable logistic regression analysis (MLRA) were used to identify determinants associated with MDR-TB.

          Results

          A total of 124 respondents, 31 cases and 93 controls were participated in the study. MLRA identified six significant independent risk factors for the occurrence of MDR-TB as follows: monthly income of the family (Odds ratio (OR) = 3.71; 95% Confidence Interval (CI) = 1.22–11.28), defaulting from treatment (OR = 3.33; 95% CI = 1.14–9.09), stigma associated with TB (OR = 2.97; 95% CI = 1.18–7.45), subjective feeling of sadness (OR = 4.05; 95% CI = 1.69–9.70), use of sedatives (OR = 2.79; 95% CI = 1.02–7.65) and chronic obstructive pulmonary disease (OR = 4.51; 95% CI = 1.07–18.96).

          Conclusion

          In order to reduce burden of drug resistance, strategies of controlling MDR-TB in Serbia should emphasize multi-sectorial actions, addressing health care and social needs of TB patients.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.

          The resurgence of tuberculosis (TB) in western countries has been attributed to the HIV epidemic, immigration, and drug resistance. Multidrug resistant tuberculosis (MDR-TB) is caused by the transmission of multidrug resistant Mycobacterium tuberculosis strains in new cases, or by the selection of single drug resistant strains induced by previous treatment. The aim of this report is to determine risk factors for MDR-TB in Europe. A systematic review was conducted of published reports of risk factors associated with MDR-TB in Europe. Meta-analysis, meta-regression, and sub-grouping were used to pool risk estimates of MDR-TB and to analyse associations with age, sex, immigrant status, HIV status, occurrence year, study design, and area of Europe. Twenty nine papers were eligible for the review from 123 identified in the search. The pooled risk of MDR-TB was 10.23 times higher in previously treated than in never treated cases, with wide heterogeneity between studies. Study design and geographical area were associated with MDR-TB risk estimates in previously treated patients; the risk estimates were higher in cohort studies carried out in western Europe (RR 12.63; 95% CI 8.20 to 19.45) than in eastern Europe (RR 8.53; 95% CI 6.57 to 11.06). National estimates were possible for six countries. MDR-TB cases were more likely to be foreign born (odds ratio (OR) 2.46; 95% CI 1.86 to 3.24), younger than 65 years (OR 2.53; 95% CI 1.74 to 4.83), male (OR 1.38; 95% CI 1.16 to 1.65), and HIV positive (OR 3.52; 95% CI 2.48 to 5.01). Previous treatment was the strongest determinant of MDR-TB in Europe. Detailed study of the reasons for inadequate treatment could improve control strategies. The risk of MDR-TB in foreign born people needs to be re-evaluated, taking into account any previous treatment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Prevalence and correlates of depression and anxiety among patients with tuberculosis at WolaitaSodo University Hospital and Sodo Health Center, WolaitaSodo, South Ethiopia, Cross sectional study

            Background Anxiety and depression are frequently and highly occurring mental disorders in patients with tuberculosis. When depression and anxiety co-morbid with tuberculosis, it leads to poor adherence to anti TB medication, which is important barrier to global control of tuberculosis & increases the risk of morbidity and mortality due to TB. Cross sectional study was conducted to assess prevalence and correlates of depression and anxiety among patients with TB at WolaitaSodo University Hospital and Sodo Health Center, WolaitaSodo, Ethiopia. Methods Institution based cross-sectional study was conducted in 2014.A total of 417 TB patients, who had regular follow up at WolaitaSodo University Hospital and Sodo Health Center, WolaitaSodo, South Ethiopia, were recruited to assess depression and anxiety and its associated correlates. Depression and anxiety were assessed through face to face interviews by trained psychiatry nurses using the hospital anxiety and depression scale (HADS). Correlates for depression and anxiety were assessed using a structured questionnaire, Oslo social support scale and TB stigma Scale. Results The prevalence of depression and anxiety among patients with TB were 43.4 % (181) and 41.5 % (173) respectively. When we adjusted for the effect of potential confounding variables, patients who had co-morbid HIV infection [AOR = 5.90,(95 % CI: 2.34,15.93)], poor social support [AOR = 18.06, (95 % CI:11.21,25.45)] & perceived TB stigma [AOR = 10.86, (95 % CI:10.26,23.47)] were more likely to have depression as compared to individuals who had no co-morbid HIV infection, good social support and no perceived TB stigma respectively. Patients who had co-morbid HIV infection [AOR = 9.61,(95 % CI:3.56,25.96)], poor social support [AOR = 8.93,(95 % CI: 5.01,15.94)], perceived TB stigma [AOR = 3.11,(95 % CI:1.78,5.42)], being female [AOR = 1.72 (95 % CI: 1.06, 2.95)], current substance use[AOR = 4.88, (95 % CI: 1.79, 13.28)] and being on intensive phase of TB treatment [AOR = 1.91, (95 % CI: 1.08, 3.39)] were more likely to have anxiety as compared to individuals who had no co-morbid HIV infection, good social support, no perceived TB stigma, being male and being on continuous phase of TB treatment respectively. Conclusion Developing guidelines and training of health workers in TB clinics is useful to screen and treat depression and anxiety among TB patients.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tuberculosis and stigmatization: pathways and interventions.

              The institutional and community norms that lead to the stigmatization of tuberculosis (TB) are thought to hinder TB control. We performed a systematic review of the literature on TB stigma to identify the causes and evaluate the impact of stigma on TB diagnosis and treatment. Several themes emerged: fear of infection is the most common cause of TB stigma; TB stigma has serious socioeconomic consequences, particularly for women; qualitative approaches to measuring TB stigma are more commonly utilized than quantitative surveys; TB stigma is perceived to increase TB diagnostic delay and treatment noncompliance, although attempts to quantify its impact have produced mixed results; and interventions exist that may reduce TB stigma. Future research should continue to characterize TB stigma in different populations; use validated survey instruments to quantify the impact of TB stigma on TB diagnostic delay, treatment compliance, and morbidity and mortality; and develop additional TB stigma-reduction strategies.
                Bookmark

                Author and article information

                Contributors
                maja_stosic@batut.org.rs
                dejana.vukovic@med.bg.ac.rs
                babicdra@gmail.com
                mdrozren@gmail.com
                kfoley@wakehealth.edu
                isidora792000@yahoo.com
                +381 64 1013022 , sandra.grujicic2014@gmail.com
                Journal
                BMC Public Health
                BMC Public Health
                BMC Public Health
                BioMed Central (London )
                1471-2458
                12 September 2018
                12 September 2018
                2018
                : 18
                : 1114
                Affiliations
                [1 ]Department of HIV/AIDS, STIs, Viral Hepatitis and TB, Public Health Institute of Serbia, “Dr Milan Jovanovic Batut”, Dr Subotica 5, Belgrade, 11000 Serbia
                [2 ]ISNI 0000 0001 2166 9385, GRID grid.7149.b, Institute of Social Medicine, Faculty of Medicine, , Belgrade University, ; Dr Subotica 9, Belgrade, 11000 Serbia
                [3 ]ISNI 0000 0001 2166 9385, GRID grid.7149.b, Institute of Medical Statistics and Informatics, Faculty of Medicine, , Belgrade University, ; Dr Subotica 9, Belgrade, 11000 Serbia
                [4 ]Special Hospital for Lung Diseases, „Ozren”Ozrenska bb, Sokobanja, 18230 Serbia
                [5 ]ISNI 0000 0001 2185 3318, GRID grid.241167.7, Department of Social Sciences and Health Policy, Division of Public Health Sciences, , Wake Forest School of Medicine, ; Winston-Salem, North Carolina USA
                [6 ]ISNI 0000 0001 2166 9385, GRID grid.7149.b, Institute of Epidemiology, Faculty of Medicine, , Belgrade University, ; Visegradska 26, Belgrade, 11000 Serbia
                Author information
                http://orcid.org/0000-0001-8257-3774
                Article
                6021
                10.1186/s12889-018-6021-5
                6134722
                30208864
                672625d3-ffef-4895-9ff1-89816639f554
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 27 April 2018
                : 6 September 2018
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2018

                Public health
                tuberculosis,multidrug –resistance,risk factors,case-control study
                Public health
                tuberculosis, multidrug –resistance, risk factors, case-control study

                Comments

                Comment on this article